The effects of Palbociclib and Ferulic acid combination on cellular processes in breast cancer
Abstract Breast cancer remains a major cause of cancer-related morbidity and mortality worldwide, highlighting the urgent need for novel therapeutic approaches. In this study, we aimed to investigate the combined effects of Palbociclib (PLB), a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, and Fer...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer
2026-03-01
|
| Reeks: | Discover Oncology |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1007/s12672-026-04779-7 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|